Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Strengths-based Intervention Based on Salutogenic Theory to Promote Sense of Coherence and Self-care of Elderly People With Type 2 Diabetes

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03237975
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:29.109578+00:00
Published At
2017-08-03T00:00:00+00:00
Record Updated At
2017-08-03
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Diabetes Mellitus, Type 2", "Sense of Coherence", "Self Care", "Strengths-based Intervention"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-08-03"
protocolSection.identificationModule.nctId
"NCT03237975"
protocolSection.identificationModule.officialTitle
"A Strengths-based Intervention Based on Salutogenic Theory to Promote Sense of Coherence and Self-care of Elderly People With Type 2 Diabetes"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Diabetes Mellitus, Type 2 (protocolSection.conditionsModule.conditions)
  • Sense of Coherence (protocolSection.conditionsModule.conditions)
  • Self Care (protocolSection.conditionsModule.conditions)
  • Strengths-based Intervention (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.